T. Rowe Price Investment Management »

Immunovant shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $43M 1.6M 26.40

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Alphabet Comm Stk (GOOGL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Nvidia Corporation Comm Stk (NVDA)
Unitedhealth Group Comm Stk (UNH)
Fortive Corp Comm Stk (FTV)
Waste Connections Comm Stk (WCN)
Danaher Corporation Comm Stk (DHR)
Roper Technologies Comm Stk (ROP)
Intuit Comm Stk (INTU)
Intercontinental Exchange In Comm Stk (ICE)
Revvity Comm Stk (RVTY)
Becton Dickinson & Co Comm Stk (BDX)
Marvell Technology Comm Stk (MRVL)

View all positions for T. Rowe Price Investment Management

Top funds holding Immunovant

Vanguard Group
BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Viking Global Investors
Perceptive Advisors
Alpine Partners VI
Woodline Partners
T. Rowe Price Investment Management
Geode Capital Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Pictet Asset Management Holding SA
Rock Springs Capital Management

View all funds holding Immunovant